Search results

Sort by:

Filter by:

  1. UCSFi001-A-1 (AICS-0005-050)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  2. UCSFi001-A-2 (AICS-0012-105)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  3. UCSFi001-A-3 (AICS-0016-184)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  4. UCSFi001-A-4 (AICS-0075-085)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  5. UCSFi001-A-5 (AICS-0011-027)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  6. UCSFi001-A-6 (AICS-0013-210)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  7. UCSFi001-A-7 (AICS-0017-065)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  8. UCSFi001-A-8 (AICS-0010-055)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  9. UCSFi001-A-9 (AICS-0014-006)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  10. UCSFi001-A-10 (AICS-0023-020)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  11. UCSFi001-A-11 (AICS-0024-080)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  12. UCSFi001-A-12 (AICS-0036-006)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  13. UCSFi001-A-13 (AICS-0022-037)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  14. UCSFi001-A-14 (AICS-0025-001)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  15. UCSFi001-A-15 (AICS-0025-044)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  16. UCSFi001-A-16 (AICS-0031-035)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  17. UCSFi001-A-17 (AICS-0032-019)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  18. UCSFi001-A-18 (AICS-0030-022)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  19. UCSFi001-A-19 (AICS-0033-115)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  20. UCSFi001-A-20 (AICS-0040-013)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  21. UCSFi001-A-21 (AICS-0040-035)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  22. UCSFi001-A-22 (AICS-0053-016)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  23. UCSFi001-A-23 (AICS-0054-091)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  24. UCSFi001-A-24 (AICS-0057-050)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  25. UCSFi001-A-25 (AICS-0058-067)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  26. UCSFi001-A-26 (AICS-0037-172)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  27. UCSFi001-A-27 (AICS-0048-039)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  28. UCSFi001-A-28 (AICS-0061-036)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  29. UCSFi001-A-29 (AICS-0052-003)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  30. UCSFi001-A-30 (AICS-0046-051)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  31. UCSFi001-A-31 (AICS-0069-088)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  32. UCSFi001-A-32 (AICS-0060-027)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  33. UCSFi001-A-33 (AICS-0059-036)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  34. UCSFi001-A-34 (AICS-0068-009)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  35. UCSFi001-A-35 (AICS-0080-069)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  36. UCSFi001-A-36 (AICS-0036-028)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  37. UCSFi001-A-37 (AICS-0074-026)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  38. UCSFi001-A-38 (AICS-0084-018)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  39. ASGRCi001-A (F3-2#5 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  40. ASGRCi002-A (F3-3#1 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 1 diabetes mellitus

  41. ASGRCi003-A (F3-4#5 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 1 diabetes mellitus

  42. ASGRCi004-A (0118 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Proliferative diabetic retinopathy

    Disease:

    Type 2 diabetes mellitus

  43. ASGRCi005-A (0622 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 2 diabetes mellitus

    Disease:

    Keratoconjunctivitis sicca

  44. ASGRCi006-A (0808 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 2 diabetes mellitus

    Disease:

    Proliferative diabetic retinopathy

  45. BCMi001-A (M22c5 and HSCC-003iPS-Sc5)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  46. BCRTi001-A (P01-1)

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Fibrodysplasia ossificans progressiva

  47. BCRTi002-A (P02-1)

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Fibrodysplasia ossificans progressiva

  48. BCRTi004-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Normal (normalities, health, normalcy, normality)

  49. BCRTi005-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Normal (normalities, health, normalcy, normality)

  50. BIHi001-A (BCRT-3 and BCRT#1)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  51. BIHi002-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Autosomal recessive osteopetrosis 4

  52. BIHi004-A (NHDF Epi5 Cl5 iPSC)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  53. BIHi005-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  54. BIHi005-A-4

    Germany Berlin Institute of Health (BIH)
    Disease:

    Myocardial infarction

  55. BIHi005-A-5

    Germany Berlin Institute of Health (BIH)
    Disease:

    Alzheimer's disease

  56. BIHi006-D

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  57. BIHi007-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  58. BIHi008-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  59. BIHi009-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  60. BIHi010-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  61. BIHi011-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  62. BIHi012-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  63. BIHi015-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  64. BIHi016-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  65. BIHi017-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  66. BIHi018-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  67. BIHi019-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  68. BIHi024-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  69. BIHi025-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  70. BIHi028-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  71. BIHi029-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  72. BIHi030-C

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  73. BIHi031-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  74. BIHi032-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  75. BIHi038-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  76. WTSIi227-A-1 (WETU LRP2 KO)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Donnai-barrow syndrome

  77. STBCi006-A-1 (ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  78. STBCi006-A-3 (ApoE 3/3)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  79. STBCi006-A-4 (ApoE 3/4)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  80. BIONi010-A (K1P53)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  81. BIONi010-B (K2P53 and BIONi010-B)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  82. BIONi010-C (BIONi010-C and K3P53)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  83. BIONi010-C-2 (BIONi010-C ApoE E3/E3 #H8 P32)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  84. BIONi010-C-3 (BIONi010-C ApoE KO #KO30 P30)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  85. BIONi010-C-4 (BIONi010-C ApoE E4/E4 #B44 P27)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  86. BIONi010-C-5 (BIONi010-C CD33 E2del #N14 P26)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  87. BIONi010-C-6 (BIONi010-C ApoE E2/E2)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  88. BIONi010-C-7 (BIONi010-C Trem2 R47H)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  89. BIONi010-C-8 (BIONi010-C Trem2 T66M and #Y5-80)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  90. BIONi010-C-9 (BIONi010-C CD33 KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  91. BIONi010-C-10 (HNF1AP291fsinsC +/- 54-5)

    Denmark Bioneer (BION)
    Disease:

    Mody

  92. BIONi010-C-11 (HNF1AP291fsinsC -/- 66-1)

    Denmark Bioneer (BION)
    Disease:

    Mody

  93. BIONi010-C-12 (HNF4ApR309C -/- 2-4)

    Denmark Bioneer (BION)
    Disease:

    Mody

  94. BIONi010-C-13 (BIONi010-C + NGN2 #I7-26)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  95. BIONi010-C-15 (BIONi010-C +dox inducible NGN2-GFP)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  96. BIONi010-C-17 (BIONi010-C TREM2 KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  97. BIONi010-C-18 (BIONi010-C TBK1 KO)

    Denmark Bioneer (BION)
    Disease:

    Inflammatory disease

  98. BIONi010-C-19 (BIONi010-C IKBKE KO)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  99. BIONi010-C-24 (BIONi010-C Dox a-syn)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  100. BIONi010-C-25 (BIONi010-C heterozygous TREM2 KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  101. UKBi011-A-1 (iLB-AD + ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  102. UKBi011-A-2 (ApoE 2/2)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  103. UKBi011-A-3 (ApoE 3/3)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  104. UKBi011-A-4 (ApoE 3/4)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  105. BIONi013-A (H240715 47-1 and SAMEA4342502)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  106. BIONi014-A (H270715 47-1 and SAMEA4342566)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  107. BIONi015-A (H280715 47-1 and SAMEA4342649)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  108. BIONi016-A (H310715 47-1)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  109. BIONi017-A (H030815 47-1 and SAMEA4451663)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  110. BIONi018-A (H050815 48-4 and SAMEA4451665)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  111. BIONi019-A (H060815 48-3 and SAMEA4451667)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  112. BIONi020-A (H070815 47-2 and SAMEA4451669)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  113. BIONi021-A (H100815 48-2 and SAMEA4451671)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  114. BIONi022-A (H110815 47-2 and SAMEA4451673)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  115. BIONi023-A (H130815 47-4 and SAMEA4454014)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  116. BIONi024-A (H170815 47-2 and SAMEA4454016)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  117. BIONi025-A (H210815 48-3 and SAMEA4454018)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  118. BIONi026-A (H300715 48-3)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  119. BIONi027-A (H040815 48-1 and SAMEA4455499)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  120. BIONi028-A (H120815 48-1 and SAMEA4455501)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  121. BIONi029-A (H190815 47-1 and SAMEA4455503)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  122. BIONi030-A (H200815 47-1 and SAMEA4455505)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  123. BIONi031-A (H240815 48-2 and SAMEA4455507)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  124. BIONi032-A (H250815 48-1 and SAMEA4455509)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  125. BIONi033-A (H180615 and SAMEA4563389)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  126. BIONi034-A (H290715 and SAMEA4563391)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  127. BIONi035-A (H180815 and SAMEA4563393)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  128. BIONi037-A (16423 ApoE3/3 (control line))

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  129. BIONi037-A-1 (16423 ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  130. BIOTi001-A (BIOT-7183-PSEN1)

    Hungary BioTalentum Ltd. (BIOT)
    Disease:

    Alzheimer's disease

  131. BIONi037-A-2 (BIONi037-A ApoE2/2 #M10-7)

    Denmark Bioneer (BSC)
    Disease:

    Alzheimer's disease

  132. BIONi037-A-3 (BIONi037-A ApoE3/4 #P10-22)

    Denmark Bioneer (BSC)
    Disease:

    Alzheimer's disease

  133. BIONi037-A-4 (BIONi037-A ApoE4/4 #I10-53)

    Denmark Bioneer (BSC)
    Disease:

    Alzheimer's disease

  134. BUCREMi001-A (iPSC-S6D63H-1-hom)

    United States Boston University (BUCREM)
    Disease:

    Sirt6

  135. BUCREMi002-A (iPSC-S6D63H-3hom)

    United States Boston University (BUCREM)
    Disease:

    Sirt6

  136. CAMi001-A (KiPS c1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  137. CAMi002-A (FiPS 2a)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  138. CAMi002-B (FiPS 2b)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  139. CAMi002-C (FiPS 2c)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  140. CAMi004-A (AdiPS 1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  141. CAMi005-A (O27Tat)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  142. CAMi005-B (2F8)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  143. CBi001-A (XLC-348)

    United States Creative Bioarray (CB)
    Disease:

    Schizophrenia

  144. CBi002-A (XLC303 and CSC-C00122)

    United States Creative Bioarray (CB)
    Disease:

    Schizophrenia

  145. TMOi001-A-1 (hiPSC-CD34-GFP-3G6)

    Austria Children's Cancer Research Institute St. Anna Kinderkrebsforschung e. V. (CCRI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  146. CDIi001-A (01279)

    United States FUJIFILM Cellular Dynamics, Inc. (CDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  147. CDIi004-A (11713)

    United States FUJIFILM Cellular Dynamics, Inc. (CDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  148. CENSOi001-B (FB78R2c2 and CENSOi249)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Dmd

  149. CENSOi002-B (FB74R2c4 and CENSOi261)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Dmd

  150. CENSOi003-B (FB79R2c6 and CENSOi258)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Dmd

  151. CENSOi005-A (FB76R2c5 and CENSOi245)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Dmd

  152. CENSOi007-A (FB75R2c5 and CENSOi255)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Dmd

  153. CENSOi008-A (FB77R2c3 and CENSOi260)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Myotonic dystrophy type 1

  154. CHDIi001-A (#1c8)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  155. CHDIi002-A (#2c3)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  156. CHDIi003-A (#3c1)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  157. CHDIi004-A (#4c2)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  158. CHDIi005-A (#5c4)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  159. CHDIi006-A (#6c7)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  160. CHDIi008-A (#8c3)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  161. CHDIi010-A (#10c2)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  162. CHDIi011-A (#11c2)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  163. CHDIi013-A (#13c5)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  164. CHDIi014-A (#14c1)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  165. CHDIi016-A (#16c6)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  166. CHDIi017-A (#17c1)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  167. CHDIi018-A (#18c1)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  168. CHDIi019-A (#19c9)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  169. CHDIi020-A (#20c2)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  170. CHDIi021-A (#21c5)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  171. CHDIi022-A (#22c1)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  172. CHDIi023-A (#23c8)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  173. CHDIi024-A (#24c7)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  174. CHDIi026-A (#26c3)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  175. CHDIi027-A (#27c4)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  176. CHDIi028-A (#28c3)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  177. CHDIi029-A (#29c4)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  178. CHDIi031-A (#31c1)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  179. CHDIi033-A (#104c2)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  180. CHDIi034-A (#105c1)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  181. CHDIi035-A (#108c5)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  182. CHDIi036-A (#110c5)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  183. CHDIi038-A (#112c7)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  184. CHDIi040-A (#115c6)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  185. CHDIi041-A (#116c2)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  186. CHDIi042-A (#117c5)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  187. CHDIi043-A (#118c6)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  188. CHDIi044-A (#120c3)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  189. CHDIi045-A (#121c6)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  190. CHDIi046-A (#122c1)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  191. CHDIi047-A (#123c6)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  192. CHDIi048-A (#125c2)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  193. CHDIi049-A (#127c2)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  194. CHDIi050-A (#128c3)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  195. CHDIi051-A (#129c1)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  196. CHDIi054-A (#132c3)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  197. CHDIi055-A (#133c5)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  198. CHDIi056-A (#134c3)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  199. CHOPi001-A (CHOPJMML1854)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Juvenile myelomonocytic leukemia

  200. CHUQi001-A (522-2666-2 and SAMEA104271492)

    Canada CHU de Québec-Université Laval Research Center (CHUQ)
    Disease:

    Myotonic dystrophy type 1

  201. CIMHi001-A (CIMHi44f028#4)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  202. CIMHi002-A (CIMHi29m067#3)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  203. CIMHi003-A (CIMHi23m035#2)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  204. CRMi001-A (NCRM-5 and NL-5)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  205. CRMi003-A (NCRM-1 and NL-1)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  206. CRMi004-A (CR0000007, NCRM-2 and ND50030)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  207. CRMi005-A (CR0000011, ND50021 and ND1.4)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  208. CRTDi001-A (T12.9 and C1-1)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  209. CSSi001-A (Joub03cl2 and COR419)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Joubert syndrome

  210. CSSi002-A (HD8yrs)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Juvenile huntington disease

  211. CSSi003-A (COL04 clE2)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Smith-magenis syndrome

  212. CSSi004-A (HD256.05 cl1)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Huntington disease

  213. CSSi005-A (COL03 cl.C3)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  214. CSSi006-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Huntington disease

  215. CSSi007-A (Joub07 cl1 and COR11-NG708)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Joubert syndrome

  216. CSSi008-A (AT214-01-02)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Dentatorubral pallidoluysian atrophy

  217. CSSi009-A (GDB1307_Z2#1)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
  218. CSUXHi001-A

    China Xiangya Hospital (CSUXH)
    Disease:

    Spinocerebellar ataxia type 3

  219. CUBi001-A

    Germany Charité - Universitätsmedizin Berlin (CUB)
  220. CUBi002-B

    Germany Charité - Universitätsmedizin Berlin (CUB)
  221. DANi001-C (iPS-CCD-C3)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Normal (normalities, health, normalcy, normality)

  222. DANi002-C (GBA-002-C3)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  223. DANi003-H (GBA-003-C8)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  224. DANi004-A (PRKN-004-C1)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  225. DANi005-A (LRRK2-GBA-005-C1)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  226. DANi006-F (GBA-006-C6)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  227. DANi007-A (PINK1-007-C1)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  228. DANi008-F (SNCA-008-C6)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  229. DANi009-C (SNCA-009-C3)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  230. DANi010-A (GBA-010-C1)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  231. DANi011-A (LRRK2-011-C1)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  232. EDi001-A (AST22, AST23 and SAMEA3319992)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  233. EDi001-A-1 (AST22-C and AST23-C)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  234. EDi001-A-2 (AST23-1KO-3, AST22-1KO-3, AST-23_SCAKO Clone 3 and AST-22_SNCAKO Clone 3)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  235. EDi001-A-3 (AST23_SNCAKO Clone 1, AST22-1KO-1, AST23-1KO-1 and AST22_SNCAKO Clone 1)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  236. EDi001-A-4 (AST22-2KO-6, AST23_SNCAKO Clone 6, AST22_SNCAKO Clone 6 and AST23-2KO-6)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  237. EDi002-A (NAS2)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  238. EDi008-B (G51D-4, EDINi008-B, EDIi008-B and SAMEA3174606)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  239. EDi010-A (RCi136)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  240. EDi010-B (RCi138)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  241. EDi011-A (RCi139)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  242. EDi011-B (RCi140)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  243. EDi011-C (RCi141)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  244. EDi012-A (RCi163)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  245. EDi012-B (RCi164)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  246. EDi012-C (RCi165)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  247. EDi013-A (RCi192)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  248. EDi013-B (RCi193)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  249. EDi013-C (RCi214)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  250. EDi014-A (RCi175)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

    Disease:

    Anti-social behavior

  251. EDi014-B (RCi185)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

    Disease:

    Anti-social behavior

  252. EDi015-A (RCi176)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

  253. EDi015-B (RCi183)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

  254. EDi015-C (RCi184)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

  255. EDi016-A (RCi189)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  256. EDi016-C (RCi191)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  257. EDi017-A (RCi174)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  258. EDi017-B (RCi181)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  259. EDi017-C (RCi182)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  260. EDi018-A (RCi211)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  261. EDi018-B (RCi212)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  262. EDi018-C (RCi213)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  263. EDi019-A (RCi166)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  264. EDi019-B (RCi167)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  265. EDi019-C (RCi168)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  266. EDi021-A (CS0395iCTR-LBCn3)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  267. EDi022-A (CS0617iCTR-LBCn1)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  268. EDi023-A (CS0791iCTR-LBCn1)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  269. EDi024-A (CS0036iCTR-LBCn2)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  270. EDi025-A (CS0051iCTR-LBCn3)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  271. EDi026-A (CS0087iCTR-LBCn1)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  272. EDi027-A (CS1045iCTR-LBCn1)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  273. EDi028-A (CS0172iCTR-LBCn2)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  274. EDi029-A (CS0188iCTR-LBCn3)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  275. EDi030-A (CS0228iCTR-LBCn3)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  276. EDi031-A (CS0416iCTR-LBCn1)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  277. EDi032-A (CS0424iCTR-LBCn3)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  278. EDi033-A (CS0459iCTR-LBCn5)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  279. EDi034-A (CS0465iCTR-LBCn2)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  280. EDi035-A (CS0484iCTR-LBCn3)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  281. EDi036-A (CS0594iCTR-LBCn2)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  282. EDi037-A (CS0702iCTR-LBCn1)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  283. EDi038-A (CS0771iCTR-LBCn5)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  284. EDi039-A (CS0809iCTR-LBCn7)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  285. EDi040-A (CS0908iCTR-LBCn3)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  286. EDi041-A (CS1031iCTR-LBCn6)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  287. EDi042-A (CS1034iCTR-LBCn3)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  288. EDi043-A (CS1050iCTR-LBCn3)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  289. EDi044-A (CS1185iCTR-LBCn2)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  290. EDi045-A (CS1247iCTR-LBCn2)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  291. EPFLi001-A (hiPS43)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  292. EPFLi002-A (hiPS9)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  293. EPFLi003-A (hiPS6)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  294. EPFLi004-A (hiPS2)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  295. EPFLi005-A (hiPS45)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  296. EPFLi006-A (hiPS14)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  297. ESi001-A (SPO2#1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Parkinson's disease

  298. ESi002-A (SP08#1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Parkinson's disease

  299. ESi003-A ([CRTRd]FiPS3819-4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    X-linked creatine transporter deficiency

  300. ESi004-A ([GD]FiPS-4F-21c)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Gaucher disease

  301. ESi005-A (cFA404-KiPS4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Fanconi anemia

  302. ESi005-B (cFA404-KiPS4F-3)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Fanconi anemia

  303. ESi006-A (SP13#4)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Parkinson's disease

  304. ESi007-A (CBiPS1sv-4F-40)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  305. ESi008-A (KiPS4F-8)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  306. ESi008-B (KiPS3F-7)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  307. ESi028-A (KiPS4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  308. ESi030-A (GA-FiPS4F)

    Spain Spanish Stem Cell Bank (ES)
  309. ESi031-A (XFiPS-F44-3F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  310. ESi031-B (FiPS-3F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  311. ESi031-C (FiPS-4F-8)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  312. ESi031-D (FiPS-4F-7)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  313. ESi032-A (XFiPS-F44-3F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  314. ESi033-A (CBiPS6-2F-4)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  315. ESi034-A (CBiPS30-4F-3)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  316. ESi034-B (CBiPS30-4F-5)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  317. ESi035-A (AD]FiPSAG07645-4F-17)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Alzheimer's disease

  318. ESi036-A ([CRTRd]FiPS3067-4F-9)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Creatine transporter deficiency

  319. ESi037-A (HKiPS-4F)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  320. ESi038-A (CBiPS32-2F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  321. ESi038-B (CBiPS32-3F-10)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  322. ESi038-C (CBiPS32-3F-12)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  323. ESi040-A ([PD] FiPS006-4F-11)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Parkinson's disease

  324. ESi041-A (CBiPS 2F-1c)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  325. ESi041-B (CBiPS 4F-3a)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  326. ESi041-C (CBiPS 4F 10b)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  327. ESi042-A ([TSD] FiPS-4F-3-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Tay-sachs disease

  328. ESi043-A ([ctrl.PD] FiPS005-4F-9)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  329. ESi044-A (FiPS Ctrl1-mR5F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  330. ESi044-B (FiPS Ctrl1-Ep6F-5)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  331. ESi044-C (FiPS Ctrl1-SV4F-7)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  332. ESi044-D (FiPS Ctrl1-R4F-4)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  333. ESi045-A (FiPS Ctrl2-mR5F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  334. ESi045-B (FiPS Ctrl2-Ep6F-8)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  335. ESi045-C (FiPS Ctrl2-SV4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  336. ESi045-D (FiPS Ctrl2-R4F-5)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  337. ESi046-A ([UCiPS] Ctrl5-R4F-25)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  338. ESi048-A (MS FiPS 1-R4F-3)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  339. ESi049-A (MS FiPS 2 R4F-10)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  340. ESi050-A (MS FiPS 3-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  341. ESi051-A (MS FiPS 4-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  342. ESi052-A (MS FiPS 5-R4F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  343. ESi053-A (MS FiPS 6-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  344. ESi054-A (AS FiPS 1-Ep6F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Alport syndrome

  345. ESi055-A (AS FiPS 2-Ep6F-28)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Alport syndrome

  346. ESi056-A (AS FiPS 3-Ep6F-9)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Alport syndrome

  347. ESi057-A ([DUP7] FiPS-4F-3-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  348. ESi057-B ([DUPSW] FiPS301-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  349. ESi058-A ([DUP7] FiPS-4F-4-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  350. ESi058-B ([DUP7] FiPS4-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  351. ESi059-A ([SWB] FiPS-4F-1-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams syndrome

  352. ESi059-B ([SWB] FiPS1-R4F-5)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams syndrome

  353. ESi060-A ([SWB] FiPS-4F-5-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams syndrome

  354. ESi060-B ([SWB] FiPS5-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams syndrome

  355. ESi065-A ([IDDM1] FiPS 1.13-Ep6F-9)

    Spain Spanish Stem Cell Bank (ES)
  356. ESi068-A (SWB FiPS 159-R4F-4)

    Spain Spanish Stem Cell Bank (ES)
  357. ESi069-A (SWB FiPS 344-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
  358. ESi070-A (DUPSW FiPS 501-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  359. ESi071-A (DUPSW FiPS 701-R4F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  360. ESi072-A (OCD FiPS 1-EP6F-16)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsessive-compulsive disorder

  361. ESi073-A (OCD FiPS 2-EP6F-10)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsessive-compulsive disorder

  362. ESi074-A (CT PBiPS1-Sv4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Cardiotoxicity

  363. ESi075-A (BST PBiPS1-Sv4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  364. ESi076-A (BST PBiPS2-Sv4F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  365. FAMRCi001-A (ARVC2)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Arrhythmogenic right ventricular cardiomyopathy

  366. FAMRCi001-B (ARVC4)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Arrhythmogenic right ventricular cardiomyopathy

  367. FAMRCi002-A (OBC7)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Desminopathy

  368. FAMRCi003-A (108-1)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  369. FAMRCi003-B (108-2)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  370. FAMRCi004-A (DSPL1)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Sick sinus syndrome

    Disease:

    Atrioventricular block

    Disease:

    Familial progressive cardiac conduction defect

  371. FAMRCi004-B (DSPL10)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Sick sinus syndrome

    Disease:

    Atrioventricular block

    Disease:

    Familial progressive cardiac conduction defect

  372. FAMRCi005-A (LMNA B4)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Paroxysmal ventricular tachycardia

    Disease:

    Atrioventricular block

    Disease:

    Myopathy

  373. FAMRCi005-B (LMNA B5)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Paroxysmal ventricular tachycardia

    Disease:

    Atrioventricular block

    Disease:

    Myopathy

  374. FAMRCi006-A (LMNA T3)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Emery-dreifuss muscular dystrophy

    Disease:

    Dilated cardiomyopathy

  375. FAMRCi006-B (LMNA T4)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Emery-dreifuss muscular dystrophy

    Disease:

    Dilated cardiomyopathy

  376. FAMRCi007-A (LMNA #23)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Emery-dreifuss muscular dystrophy

    Disease:

    Atrioventricular block

    Disease:

    Paroxysmal atrial fibrillation

  377. FAMRCi007-B (LMNA #19)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Emery-dreifuss muscular dystrophy

    Disease:

    Atrioventricular block

    Disease:

    Paroxysmal atrial fibrillation

  378. FJMUi001-A (hiPS-SPG76-001)

    China Fujian Medical University (FJMU)
    Disease:

    Hereditary spastic paraplegia

  379. GENYOi004-A (ASD-PBMC-iPS4F2)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Adnp syndrome

  380. GENYOi005-A (FPD/AML-PBMC-iPSC4F73)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Familial platelet disorder with associated myeloid malignancy

  381. GENYOi006-A (GRX-MCiPS4F-A2)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Normal (normalities, health, normalcy, normality)

  382. GENYOi006-A-1 (GRX-MCiPS4F-A2-ETO2-GLIS2)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Acute myeloid leukemia

  383. GENYOi006-A-2 (GRX-MCiPS4F-A2-NEO)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Normal (normalities, health, normalcy, normality)

  384. GIBHi001-A

    China Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
    Disease:

    Autism spectrum disorder

  385. GIBHi002-A (C11)

    China Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  386. GIBHi002-A-1 (C5-PARK2-KO)

    China Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
    Disease:

    Parkinson's disease

  387. GIBHi003-A (PINK1-I368N-C2)

    China Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
    Disease:

    Parkinson's disease

  388. HEBHMUi001-A

    China Hebei Medical University (HEBHMU)
    Disease:

    Parkinson's disease

  389. HEBHMUi002-A

    China Hebei Medical University (HEBHMU)
    Disease:

    Normal (normalities, health, normalcy, normality)

  390. HELPi001-A (BS-TL-1)

    China Help Stem Cell Innovations Co.Ltd. (HELP)
    Disease:

    Congenital contractural arachnodactyly

  391. HMGUi001-A (XM001)

    Germany Helmholtz Zentrum München (HMGU)
    Disease:

    Normal (normalities, health, normalcy, normality)

  392. HMGUi001-A-1 (hINS-T2A-H2B-Cherry (+/-) and HMGUi001-A-1)

    Germany Helmholtz Zentrum München (HMGU)
    Disease:

    Normal (normalities, health, normalcy, normality)

  393. HMGUi002-A (XM002)

    Germany Helmholtz Zentrum München (HMGU)
    Disease:

    Normal (normalities, health, normalcy, normality)

  394. HUBi001-A (HUB001Ai)

    Netherlands The Hubrecht Institute (HUB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  395. HVRDi004-B (GM23338)

    United States Harvard University (HVRD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  396. HVRDi004-B-1 (ENCBS369AAA and iNGN)

    United States Harvard University (HVRD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  397. HVRDi005-A (BJ SiPS-D)

    United States Harvard University (HVRD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  398. HVRDi006-A (18b healthy control)

    United States Harvard University (HVRD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  399. HVRDi007-A (DiPS 1016SevA)

    United States Harvard University (HVRD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  400. HVRDi008-A (SOD1-27e and 27e)

    United States Harvard University (HVRD)
    Disease:

    Amyotrophic lateral sclerosis

  401. HVRDi009-A (29e SOD1 L144F and 29e)

    United States Harvard University (HVRD)
    Disease:

    Amyotrophic lateral sclerosis

  402. HVRDi010-A (19a)

    United States Harvard University (HVRD)
    Disease:

    Amyotrophic lateral sclerosis

  403. IAIi001-A (IAIi001RSTS2-65-A)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Rubinstein-taybi syndrome

  404. IAIi002-A (IAIi002RSTS1-34-A)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Rubinstein-taybi syndrome

  405. IAIi003-A (IAIi003RSTS1-46-A)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Rubinstein-taybi syndrome

  406. IAIi004-A (IAIi004RSTS1-149-A)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Rubinstein-taybi syndrome

  407. IBMSi001-A (IBMS-iPSC-012-12)

    Taiwan Institute of Biomedical Sciences, Academia Sinica (IBMS)
    Disease:

    Autosomal dominant polycystic kidney disease

  408. IBMSi002-A (IBMS-iPSC-013-06)

    Taiwan Institute of Biomedical Sciences, Academia Sinica (IBMS)
    Disease:

    Autosomal dominant polycystic kidney disease

  409. IBMSi003-A (IBMS-iPSC-014-05)

    Taiwan Institute of Biomedical Sciences, Academia Sinica (IBMS)
    Disease:

    Autosomal dominant polycystic kidney disease

  410. IBPi001-A (HPrF iPSCs 20A)

    Czech Republic Institute of Biophysics of the Czech Academy of Sciences (IBP)
    Disease:

    Normal (normalities, health, normalcy, normality)

  411. IBPi002-A (P71 iPSCs 1)

    Czech Republic Institute of Biophysics of the Czech Academy of Sciences (IBP)
    Disease:

    Prostate adenocarcinoma

  412. ICGi002-A (DMD1_1)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Duchenne muscular dystrophy

  413. ICGi002-B (DMD1_4)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Duchenne muscular dystrophy

  414. ICGi002-C (DMD1_11)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Duchenne muscular dystrophy

  415. ICGi005-A (iSMA40)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 1

  416. ICGi005-B (iSMA37)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 1

  417. ICGi006-A (m3SMA13)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 2

  418. ICGi006-B (m3SMA20)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 2

  419. ICGi007-A (47Q-3Lf)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Huntington disease

  420. ICGi008-A (m55Alz-9L)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Alzheimer's disease

  421. ICGi008-B (m55Alz-15L)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Alzheimer's disease

  422. ICGi009-A (iTAF3-17 and iTAF3del17)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  423. ICGi009-B (iTAF3del37 and iTAF3-37)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  424. ICGi013-A (iTAF13-26 and iTAF13del26)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  425. ICGi013-B (iTAF13del27 and iTAF13-27)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  426. ICGi014-A (2M_iALS)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Amyotrophic lateral sclerosis

  427. ICGi015-A

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Parkinson's disease

  428. ICGi015-B

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Parkinson's disease

  429. ICGi016-A (iTaf9-11)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Mental retardation, autosomal dominant 39

  430. ICGi017-A (TAF14dup10)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  431. ICGi018-A (iHD38Q-3)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Huntington's disease

  432. IDISi001-A

    Spain Health Research Institute of Santiago de Compostela (IDIS)
    Disease:

    Cadasil

  433. IDVi001-A (iPS-NR2E3-86)

    France INSTITUT DE LA VISION (IDV)
    Disease:

    Retinitis pigmentosa

  434. IDVi002-A (iPS-PRPF31-4138)

    France INSTITUT DE LA VISION (IDV)
    Disease:

    Normal (normalities, health, normalcy, normality)

  435. IDVi005-A (hiPSC_5f)

    France INSTITUT DE LA VISION (IDV)
    Disease:

    Normal (normalities, health, normalcy, normality)

  436. IGIBi001-A (SCP28)

    India Institute of Genomics and Integrative Biology (IGIB)
    Disease:

    Sickle cell anemia

  437. IMGTi001-A (iTAF5-29)

    Russia Research Institute of Medical Genetics, TNMRC (IMGT)
    Disease:

    Monosomy 22q13

  438. IMGTi001-B (iTAF5-32)

    Russia Research Institute of Medical Genetics, TNMRC (IMGT)
    Disease:

    Monosomy 22q13

  439. IMGTi003-A (iTAF6-6)

    Russia Research Institute of Medical Genetics, TNMRC (IMGT)
  440. INSAi001-A

    Portugal Instituto Nacional de Saude Ricardo Jorge (INSA)
    Disease:

    Gaucher disease type 3

  441. INSRMi002-A (PC117_c2)

    France INSERM (INSRM)
    Disease:

    Epilepsy

  442. INSRMi003-A (PC128_c5)

    France INSERM (INSRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  443. INSRMi004-A (PC118_c7)

    France INSERM (INSRM)
    Disease:

    Epilepsy

  444. INSRMi005-A (PC119_c7)

    France INSERM (INSRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  445. INSRMi006-A (PC131_c8)

    France INSERM (INSRM)
    Disease:

    Epilepsy

  446. INSRMi007-A (pc132-c4)

    France INSERM (INSRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  447. IPTi001-A (15F0008)

    China Institute of Pharmacology and Toxicology (IPT)
    Disease:

    Alzheimer's disease

  448. IPTi002-A (15F0009)

    China Institute of Pharmacology and Toxicology (IPT)
    Disease:

    Alzheimer's disease

  449. IPTi003-A (15M0010)

    China Institute of Pharmacology and Toxicology (IPT)
    Disease:

    Alzheimer's disease

  450. IPTi004-A (15M0011)

    China Institute of Pharmacology and Toxicology (IPT)
    Disease:

    Alzheimer's disease

  451. IPTi005-A (16M0064)

    China Institute of Pharmacology and Toxicology (IPT)
    Disease:

    Normal (normalities, health, normalcy, normality)

  452. IPTi006-A (16M0065)

    China Institute of Pharmacology and Toxicology (IPT)
    Disease:

    Normal (normalities, health, normalcy, normality)

  453. IPTi007-A (16F0066)

    China Institute of Pharmacology and Toxicology (IPT)
    Disease:

    Normal (normalities, health, normalcy, normality)

  454. IRFMNi001-A (iPS clone IV)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Normal (normalities, health, normalcy, normality)

  455. IRFMNi002-A (PRM#14)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Focal segmental glomerulosclerosis

  456. IRFMNi002-B (PRM#18)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Focal segmental glomerulosclerosis

  457. IRFMNi003-A

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Normal (normalities, health, normalcy, normality)

  458. IRFMNi003-A-1 (KO PKD2#17)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Autosomal dominant polycystic kidney disease

  459. IRFMNi003-A-2 (KO PKD2#36)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Autosomal dominant polycystic kidney disease

  460. IRFMNi003-A-3 (KO PKD1#16)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Autosomal dominant polycystic kidney disease

  461. IRFMNi003-A-4 (KO PKD1#5)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Autosomal dominant polycystic kidney disease

  462. IRMBi001-A (AD-PS1 hiPSC)

    France Institute for Regenerative Medecine and Biotherapy (IRMB)
    Disease:

    Alzheimer's disease

  463. IRMBi002-A (AD-APP hiPSC)

    France Institute for Regenerative Medecine and Biotherapy (IRMB)
    Disease:

    Alzheimer's disease

  464. ISMMSi001-A (SAMEA104275576 and MFS44-E)

    United States Icahn School of Medicine at Mount Sinai (ISMMS)
    Disease:

    Marfan syndrome

  465. ISMMSi001-B (SAMEA104275577 and MFS44-16)

    United States Icahn School of Medicine at Mount Sinai (ISMMS)
    Disease:

    Marfan syndrome

  466. ISMMSi002-A (SAMEA104275578 and MFS60-12)

    United States Icahn School of Medicine at Mount Sinai (ISMMS)
    Disease:

    Marfan syndrome

  467. ISMMSi002-B (MFS60-3-1 and SAMEA104276575)

    United States Icahn School of Medicine at Mount Sinai (ISMMS)
    Disease:

    Marfan syndrome

  468. KCLi001-A (iOP118)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  469. KCLi002-A (iOP107)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  470. KCLi003-A (iOP101)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  471. KGUi001-A (AR1023)

    Germany Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital, Goethe University of Frankfurt/Main (KGU)
    Disease:

    Bipolar disorder

  472. KGUi002-A (AR1034)

    Germany Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital, Goethe University of Frankfurt/Main (KGU)
    Disease:

    Bipolar disorder

  473. KLRMMEi001-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Retinitis pigmentosa

  474. KSCBi001-A (hUSiPS2)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  475. KSCBi002-A (hFSiPS1)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  476. KSCBi002-B (hFmiPS1)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  477. KSCBi002-B-1 (hFmiPS2)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  478. KSCBi003-A (hAdMSiPS1 and hAdMSCiPS1)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  479. KSCBi005-A (CMC-hiPSC-003)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  480. KSCBi005-A-1 (CMC-hiPSC-003(Nestin-GFP) and CMC-003i-Nestin.EGFP)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  481. KSCBi005-A-2 (CMC-hiPSC-003(Sox1-GFP) and CMC-003i-Sox1.EGFP)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  482. KSCBi005-A-3 (CMC-003i-Pdx1.EGFP and CMC-hiPSC-003(PDX1-GFP))

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  483. KSCBi006-A (KNIH-OI001i-A)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Osteogenesis imperfecta type 1

  484. KSCBi007-A (KNIH-PWS001i-A)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Prader-willi syndrome

  485. KSCBi010-A (DKH005i-A and DKHi005-A)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Senior-loken syndrome

  486. KSCBi011-A (DKHi090-A and DKH090i-A)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Leber congenital amaurosis

  487. KUIFMSi004-A (201B1)

    Japan Kyoto University (KUIMS)
  488. KUIFMSi004-B (201B6)

    Japan Kyoto University (KUIMS)
  489. KUIFMSi004-C (201B7)

    Japan Kyoto University (KUIMS)
  490. KUIFMSi004-D (201B2)

    Japan Kyoto University (KUIMS)
  491. KUIFMSi004-E (201B3)

    Japan Kyoto University (KUIMS)
  492. KUIFMSi009-A (243H1)

    Japan Kyoto University (KUIMS)
  493. KUIFMSi009-B (243H7)

    Japan Kyoto University (KUIMS)
  494. KUIFMSi011-A (246G1)

    Japan Kyoto University (KUIMS)
  495. KUIFMSi011-B (246G3)

    Japan Kyoto University (KUIMS)
  496. KUIFMSi011-C (246G4)

    Japan Kyoto University (KUIMS)
  497. KUIFMSi011-D (246G5)

    Japan Kyoto University (KUIMS)
  498. KUIFMSi011-E (246G6)

    Japan Kyoto University (KUIMS)
  499. LEIi004-A

    Australia Lions Eye Institute (LEI)
    Disease:

    Retinitis pigmentosa

  500. LEIi004-A-1

    Australia Lions Eye Institute (LEI)
    Disease:

    Retinitis pigmentosa

  501. LEIi005-A

    Australia Lions Eye Institute (LEI)
    Disease:

    Retinitis pigmentosa

  502. LEIi006-A

    Australia Lions Eye Institute (LEI)
    Disease:

    Retinitis pigmentosa

  503. LUBi001-A (PGRN-8310, PGRN8310, RCi195 and RCFB58 c12.5)

    Denmark H. Lundbeck A/S (LUB)
    Disease:

    Frontotemporal dementia

  504. LUBi001-B (PGRN-8310, RCFB58 c4.4, PGRN8310 and RCi194)

    Denmark H. Lundbeck A/S (LUB)
    Disease:

    Frontotemporal dementia

  505. LUBi001-C (PGRN-8310, RCFB58 c3.7, RCi200 and PGRN8310)

    Denmark H. Lundbeck A/S (LUB)
    Disease:

    Frontotemporal dementia

  506. LUMCi002-A (113-6 and LUMC0113iATAX06)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia type 1

  507. LUMCi002-B (113-7 and LUMC0113iATAX07)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia type 1

  508. LUMCi002-C (113-8 and LUMC0113iATAX08)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia type 1

  509. LUMCi003-A (114-1 and LUMC0114iCTRL01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  510. LUMCi003-B (114-2 and LUMC0114iCTRL02)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  511. LUMCi004-A (LUMC0099iCTRL04)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  512. LUMCi007-A (LUMC0151iHD01 and 151-1)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  513. LUMCi007-B (LUMC0151iHD05 and 151-5)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  514. LUMCi008-A (152-2 and LUMC0152iHD02)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  515. LUMCi008-B (152-3 and LUMC0152iHD03)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  516. LUMCi008-C (152-4 and LUMC0152iHD04)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  517. LUMCi013-A (LUMC0133iCTRL06)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  518. LUMCi014-A (LUMC0134iCTRL29)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  519. LUMCi015-A (LUMC0135iCTRL01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  520. LUMCi016-A (LUMC0136iCTRL09)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  521. LUMCi022-A (115-1 and LUMC0115iATAX01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia type 1

  522. LUMCi022-B (115-2 and LUMC0115iATAX02)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia type 1

  523. LUMCi022-C (115-7 and LUMC0115iATAX07)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia type 1

  524. LUMCi023-A (LUMC0125iCTRL06 and 125-6)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  525. MCRIi001-A (PB001)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  526. MCRIi001-A-1 (PB001-OI26)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Osteogenesis imperfecta

  527. MCRIi001-A-2 (MCRIi001-A-SOX9tdTom and PB001-SOX9tdTom)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  528. MHHi001-A (hHSC_Iso4_ADCF_SeViPS2 (Phönix))

    Germany Hannover Medical School (MHH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  529. MHHi002-A (CF(1)iPS5)

    Germany Hannover Medical School (MHH)
    Disease:

    Cystic fibrosis

  530. MHHi003-A (CF(15)iPS10)

    Germany Hannover Medical School (MHH)
    Disease:

    Cystic fibrosis

  531. MHHi004-A (CF(16)iPS1)

    Germany Hannover Medical School (MHH)
    Disease:

    Cystic fibrosis

  532. MHHi005-A (CF(17)iPS6)

    Germany Hannover Medical School (MHH)
    Disease:

    Cystic fibrosis

  533. MHHi006-A (HSC1285_T-iPS2)

    Germany Hannover Medical School (MHH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  534. MHHi015-A (hCD34iPSC16)

    Germany Hannover Medical School (MHH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  535. MHHi015-B (hCD34iPSC11)

    Germany Hannover Medical School (MHH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  536. MICCNi001-A (ADHD Stem Cell Study_subject 6, hiPSC_03 family control sibling and clone C1)

    Australia ​Monash Institute of Cognitive and Clinical Neurosciences (MICCN)
    Disease:

    Normal (normalities, health, normalcy, normality)

  537. MICCNi001-B (ADHD Stem Cell Study_subject 6, hiPSC_03 family control sibling and clone C2)

    Australia ​Monash Institute of Cognitive and Clinical Neurosciences (MICCN)
    Disease:

    Normal (normalities, health, normalcy, normality)

  538. MICCNi002-A (ADHD Stem Cell Study_subject 5, clone A1 and hiPSC_03 affected sibling)

    Australia ​Monash Institute of Cognitive and Clinical Neurosciences (MICCN)
    Disease:

    Attention deficit hyperactivity disorder

  539. MICCNi002-B (ADHD Stem Cell Study_subject 5, hiPSC_03 affected sibling and clone A16)

    Australia ​Monash Institute of Cognitive and Clinical Neurosciences (MICCN)
    Disease:

    Attention deficit hyperactivity disorder

  540. MLi002-A (iEBS)

    Slovenia Faculty of Medicine University of Ljubljana (ML)
    Disease:

    Epidermolysis bullosa simplex

  541. MMCi001-A (MMC-iPSC-052B-02)

    Taiwan Mackay Medical College (MMC)
    Disease:

    Deafness, autosomal recessive 1a

  542. MPIi001-A

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  543. MPIi002-A (T4 and L1-1Mut)

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Parkinson's disease

  544. MPIi003-A (IM2 and L2-2Mut)

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Parkinson's disease

  545. MPIi003-A-1 (IM2GC and L2-2GC)

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Parkinson's disease

  546. MPIi005-A (SF2.1 and wt1)

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  547. MUi010-A (MYH9)

    Thailand Mahidol University (MU)
    Disease:

    Myh9-related disease

  548. MUi015-A (RB1)

    Thailand Mahidol University (MU)
    Disease:

    Retinoblastoma

  549. MUNIi001-A (DMD02)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  550. MUNIi002-A (MDMD02)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  551. MUNIi003-A (DMD03)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  552. MUNIi004-A (DMD04)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  553. NCAi001-A

    Netherlands Ncardia B.V. (NCA)
    Disease:

    Normal (normalities, health, normalcy, normality)

  554. NHLBIi001-A (MS19-ES-D)

    United States NHLBI iPSC Core (NHLBI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  555. NHLBIi001-B (MS19-ES-H)

    United States NHLBI iPSC Core (NHLBI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  556. NHLBIi003-A (ND2.0 and mND2-0)

    United States NHLBI iPSC Core (NHLBI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  557. NHLBIi003-A-1 (ND2-tdTom1)

    United States NHLBI iPSC Core (NHLBI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  558. NHLBIi003-A-2 (ND2-tdTom4)

    United States NHLBI iPSC Core (NHLBI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  559. NUIGi001-A (iPSC ARO1-11)

    Ireland National University of Ireland Galway (NUIG)
  560. NUIGi005-A (LQTS004C7 and LQT004C7)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  561. NUIGi005-B (LQTS004C9 and LQT004C9)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  562. NUIGi005-C (LQTS004Cx and LQT004Cx)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  563. NUIGi006-A (LQTS005C2 and LQT005C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  564. NUIGi006-B (LQTS005C4 and LQT005C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  565. NUIGi006-C (LQTS005Cx and LQT005Cx)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  566. NUIGi007-A (LQTS006C6 and LQT006C6)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  567. NUIGi007-B (LQTS006C8 and LQT006C8)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  568. NUIGi008-A (LQTS007C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  569. NUIGi008-B (LQTS007C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  570. NUIGi008-C (LQTS007Cx)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  571. NUIGi009-A (LQTS008C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  572. NUIGi009-B (LQTS008C6)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  573. NUIGi009-C (LQTS008Cx)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  574. NUIGi010-A (LQTS009C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  575. NUIGi010-B (LQTS009C3)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  576. NUIGi010-C (LQTS009Cx)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  577. NUIGi011-A (LQTS010C3)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  578. NUIGi011-B (LQTS010C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  579. NUIGi011-C (LQTS010Cx)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Long qt syndrome 1

  580. NUIGi022-A (ND11C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism

  581. NUIGi022-B (ND11C7)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism

  582. NUIGi023-A (ND12C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism

  583. NUIGi023-B (ND12C3)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism

  584. NUIGi024-A (CND13C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  585. NUIGi024-B (CND13C7)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  586. NUIGi025-A (ND14C8)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism

  587. NUIGi025-B (ND14C9)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism

  588. NUIGi026-A (CND15C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  589. NUIGi026-B (CND15C6)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  590. NUIGi027-A (RP001C8)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Retinitis pigmentosa

  591. NUIGi028-A (RP002C12)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Retinitis pigmentosa

  592. NUIGi029-A (RP003C12)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Retinitis pigmentosa

  593. NUIGi035-A (02V-AD)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  594. NUIGi036-A (03V-D)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  595. NUIGi039-A (ND1C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism spectrum disorder

  596. NUIGi039-B (ND1C5)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism spectrum disorder

  597. NUIGi040-A (CND1C3)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  598. NUIGi040-B (CND1C7)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  599. NUIGi041-A (ND3C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism spectrum disorder

  600. NUIGi041-B (ND3C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism spectrum disorder

  601. NUIGi042-A (CND3C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  602. NUIGi042-B (CND3C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (normalities, health, normalcy, normality)

  603. NUIGi043-A (ALS52C3)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  604. NUIGi043-B (ALS52C9)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  605. NUIGi043-C (ALS52C10)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  606. NUIGi044-A (ALS69C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  607. NUIGi044-B (ALS69C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  608. NUIGi044-C (ALS69C6)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  609. NUIGi045-A (ND2C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autism spectrum disorder

  610. NUIGi048-A (ALSH84C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  611. NUIGi048-B (ALSH84C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  612. NUIGi048-C (ALSH84C5)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  613. NUIGi049-A (ALSH47C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  614. NUIGi049-B (ALSH47C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  615. NUIGi049-C (ALSH47C3)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  616. NUIGi050-A (ALS53C5)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  617. NUIGi050-B (ALS53C6)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  618. NUIGi050-C (ALS53C7)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  619. NUIGi051-A (ALS57C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  620. NUIGi051-B (ALS57C3)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  621. NUIGi051-C (ALS57C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  622. NYSCFi001-A (AL0002-01-MR-131)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  623. NYSCFi001-B (AL0002-01-MR-132)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  624. NYSCFi001-C (AL0002-01-SV-008)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  625. NYSCFi001-D (AL0002-01-SV-010)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  626. NYSCFi002-A (AL0004-01-SV-002)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  627. NYSCFi002-B (AL0004-01-SV-008)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  628. OSRi001-A (PD-OPA1-A495V#72)

    Italy Ospedale San Raffaele (OSR)
    Disease:

    Parkinson's disease

  629. OSRi004-A (ND#37)

    Italy Ospedale San Raffaele (OSR)
    Disease:

    Normal (normalities, health, normalcy, normality)

  630. PCIi001-A

    France PHENOCELL (PCI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  631. PCIi002-A

    France PHENOCELL (PCI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  632. PCIi003-A

    France PHENOCELL (PCI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  633. PCIi004-A

    France PHENOCELL (PCI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  634. PCIi005-A

    France PHENOCELL (PCI)
    Disease:

    Danon disease

  635. PFIZi001-A (EM1-3F)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  636. RCi001-A (Thp3C-6 and RCi88)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  637. RCi001-B (RCi89 and Thp3C-9)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  638. PFIZi002-A (EM1-7M)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  639. RCi002-A (FP5C-14 and RCi92)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  640. RCi002-B (FP5C-16 and RCi93)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  641. PFIZi003-A (EM2-7M)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  642. RCi003-A (RCi115 and CIP11A-5)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Pain agnosia

  643. RCi003-B (CIP11A-9 and RCi117)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Pain agnosia

  644. PFIZi004-A (EM2-7F)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  645. PFIZi009-A (RCi188)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  646. PFIZi010-A (FB65c7)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Chromosome 16p11.2 deletion syndrome, 220kb

  647. PFIZi010-B (FB65c16)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Chromosome 16p11.2 deletion syndrome, 220kb

  648. PFIZi010-C (FB65c20)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Chromosome 16p11.2 deletion syndrome, 220kb

  649. PFIZi011-A (RCi199 and FB67c2)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Chromosome 16p11.2 deletion syndrome, 220kb

  650. PFIZi012-A (FB66c17 and RCi198)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Chromosome 16p11.2 deletion syndrome, 220kb

  651. PFIZi013-A (RCi215 and RCFB59 C9)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Amyotrophic lateral sclerosis

  652. PFIZi014-A (OD002-s7)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  653. PFIZi015-A (OD003-s5)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  654. PFIZi016-A (OD005-s9)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  655. PFIZi017-A (BC142c7 and RCi209)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  656. PFIZi018-A (BC143c8 and RCi207)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  657. PFIZi019-A (RCi202 and BC145c6)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  658. PFIZi021-A (OD001-s7)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  659. PFIZi022-A (B219c2)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  660. PFIZi023-A (B217c8)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  661. PFIZi024-A (B218c6)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  662. PFIZi025-A (B220c16)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  663. PFIZi027-A (B221c13)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  664. PFIZi028-A (B212c7)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  665. PFIZi029-A (B222c4)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  666. PFIZi030-A (B216c13)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  667. PFIZi031-A (B213c1)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  668. PFIZi032-A (B214c8)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  669. PHAi003-B (PIDi003-B)

    Sweden Pan-Hammarström laboratory (PHA)
  670. PUMCHi001-A (IPS-34)

    China Peking Union Medical College Hospital (PUMCH)
    Disease:

    Familial partial lipodystrophy type 2

  671. QBRIi001-A (Ctr1)

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  672. QBRIi001-B

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  673. QBRIi001-C

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  674. QBRIi002-A

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  675. QBRIi002-B

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  676. QBRIi002-C

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  677. QBRIi005-A

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Psoriasis

  678. QBRIi005-B

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Psoriasis

  679. QBRIi005-C

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Psoriasis

  680. QBRIi006-A

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Psoriasis

  681. QBRIi006-B

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Psoriasis

  682. QBRIi006-C

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Psoriasis

  683. RBi001-A (fb101 and RB101)

    United Kingdom R Biomedical (RB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  684. RCi004-A (PDSC-10 and RCi150)

    United Kingdom Roslin Cells (RC)
    Disease:

    Huntington disease

  685. RCi004-B (RCi68 and PDSC-3)

    United Kingdom Roslin Cells (RC)
    Disease:

    Huntington disease

  686. RCi005-A (FB71c4 and RCi171)

    United Kingdom Roslin Cells (RC)
    Disease:

    Facioscapulohumeral dystrophy

  687. RCi006-A (FB69c4 and RCi169)

    United Kingdom Roslin Cells (RC)
    Disease:

    Facioscapulohumeral dystrophy

  688. RCi007-C

    United Kingdom Roslin Cells (RC)
    Disease:

    Facioscapulohumeral dystrophy

  689. RCi009-A (Rci201 and FB73c6)

    United Kingdom Roslin Cells (RC)
    Disease:

    Facioscapulohumeral dystrophy

  690. RCPCMi002-A (HD76)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Huntington disease

  691. RCPCMi003-A (ATXN1KCl2)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
  692. RCPCMi004-A (Park14-4)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Parkinson's disease

  693. RCPCMi005-A (IPSP12-1)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Parkinson's disease

  694. RCSIi002-A (iDFU8)

    Ireland Royal College of Surgeons in Ireland (RCSI)
    Disease:

    Diabetes mellitus

  695. RCSIi003-A (iNFF12)

    Ireland Royal College of Surgeons in Ireland (RCSI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  696. RCSIi004-A (iNFF14)

    Ireland Royal College of Surgeons in Ireland (RCSI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  697. RCSIi005-A (iDFF24)

    Ireland Royal College of Surgeons in Ireland (RCSI)
    Disease:

    Diabetes mellitus

  698. REGUi001-A (IPS4FLV)

    France Institute for Regenerative Medecine & Biotherapy U1183 (REGU)
    Disease:

    Normal (normalities, health, normalcy, normality)

  699. REGUi002-A (IPS6FLV)

    France Institute for Regenerative Medecine & Biotherapy U1183 (REGU)
    Disease:

    Normal (normalities, health, normalcy, normality)

  700. RIi001-A (R.1.H.iPSC.1)

    Iran Royan Institute (RI)
  701. RIi002-A (BOM.1.H.iPSC.1)

    Iran Royan Institute (RI)
  702. RIi003-A (FHC.1.H.iPSC.3)

    Iran Royan Institute (RI)
    Disease:

    Familial hypercholesterolemia

  703. RIi004-A (GSD.1.H.iPSC.7)

    Iran Royan Institute (RI)
    Disease:

    Glycogen storage disease

  704. RIi005-A (TYR.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Tyrosinemia

  705. RIi006-A (HER.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Cholestasis

  706. RIi007-A (R.1.H.iPSC.4)

    Iran Royan Institute (RI)
  707. RIi008-A (R.1.H.iPSC.9)

    Iran Royan Institute (RI)
  708. RIi009-A (RP2.H.iPSC.3)

    Iran Royan Institute (RI)
    Disease:

    Retinitis pigmentosa

  709. RIi010-A (LCA.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Leber congenital amaurosis

  710. RIi011-A (USH.1.H.iPSC.6)

    Iran Royan Institute (RI)
    Disease:

    Usher syndrome

  711. RIi012-A (RP.1.H.iPSC.2)

    Iran Royan Institute (RI)
    Disease:

    Retinitis pigmentosa

  712. RIi013-A (ARMD.1.H.iPSC.2)

    Iran Royan Institute (RI)